# FDA Inspection 964372 - New York- Presbyterian/Queens - January 29, 2016

Source: https://www.keypedia.com/records/fda_inspections/new-york-presbyterianqueens/2864e4f4-38c8-4c3f-9251-9d72090fa63f
Source feed: FDA_Inspections

> FDA Inspection 964372 for New York- Presbyterian/Queens on January 29, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 964372
- Company Name: New York- Presbyterian/Queens
- Inspection Date: 2016-01-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 862238 - 2014-01-31](https://www.keypedia.com/records/fda_inspections/new-york-presbyterianqueens/95d13d1b-03e1-4178-bea0-2e1738806edd)
- [FDA Inspection 756843 - 2011-12-16](https://www.keypedia.com/records/fda_inspections/new-york-presbyterianqueens/81351195-176e-4ba8-b246-4f17d54a514a)
- [FDA Inspection 637009 - 2010-01-13](https://www.keypedia.com/records/fda_inspections/new-york-presbyterianqueens/73dc9a91-22cd-4d16-86f8-d2a6fd9f463a)

Company: https://www.keypedia.com/companies/new-york-presbyterianqueens/685124cd-bf6a-4ca7-8fcd-328e73de5aa9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d